20-06-2022 Haemophilia treatment and laboratory diagnostics a new era

In this Deep Dive Session, Dr. Johnny Mahlangu and Dr. Susan Louw discuss the evolution of hemophilia treatment, focusing on the transition from prophylaxis with factor replacement therapy to non-factor therapy and gene therapy. They delve into the challenges and benefits of these new therapies, including the need for different laboratory tests to monitor patients. The session also includes a detailed explanation by Dr. Louw on how to measure factor VIII and inhibitors in the presence of emicizumab.

See more from BLOODSA

Scroll to Top